Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Fig. 3

Severity categories for a BPI “worst pain” item, b average of all seven “pain interference” item scores for all patients who answered the BPI. Differences between countries p < 0.001 (Pearson’s Chi-squared test) for both “worst pain” and “pain interference.” BPI, Brief Pain Inventory; EU5, European Union 5; UK, United Kingdom

Back to article page